Intellipharmaceutics International Inc. (IPCIF)
USD 0.15
(50.0%)
USD 0.15
(50.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.38 Million | -1.38 Million | -2.46 Million | 112.1 Thousand | -12.5 Million | -6.1 Million |
| Net Income | -2.89 Million | -2.89 Million | -5.14 Million | -3.39 Million | -13.74 Million | -8.85 Million |
| Depreciation & Amortization | 206.05 Thousand | 206.05 Thousand | 261.52 Thousand | 415.37 Thousand | 612.73 Thousand | 520.83 Thousand |
| Deferred income taxes | -5521.00 | -5521.00 | -93.85 Thousand | 574.09 Thousand | 52.61 Thousand | 123.84 Thousand |
| Stock-based compensation | - | 11.98 Thousand | 71.64 Thousand | 264.56 Thousand | 927.68 Thousand | 1.74 Million |
| Change in working capital | 1.27 Million | 1.27 Million | 1.42 Million | 1.67 Million | -603.44 Thousand | -30.24 Thousand |
| Other non-cash items | 83.71 Thousand | 83.71 Thousand | 1.08 Million | 764.78 Thousand | 248.92 Thousand | 387.21 Thousand |
| Investing Cash Flow | 500 Thousand | 500 Thousand | 25.31 Thousand | 25.31 Thousand | -101.17 Thousand | -1.82 Million |
| Investments in PPE | - | - | -3875.00 | -3875.00 | -101.17 Thousand | -1.82 Million |
| Acquisitions | 482.41 Thousand | - | 30.28 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 17.58 Thousand | - | -1093.00 | 29.19 Thousand | - | - |
| Financing Cash Flow | 200 Thousand | 200 Thousand | 3.03 Million | 100.89 Thousand | 17.35 Million | 5.68 Million |
| Debt repayment | -192.96 Thousand | - | - | -461.92 Thousand | -485.65 Thousand | -164.82 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.06 Million | 3.06 Million | 27.96 Thousand | 19.64 Million | 6.54 Million |
| Other Financing Activities | 392.96 Thousand | -2.86 Million | -38.22 Thousand | 534.84 Thousand | -2.28 Million | -694.64 Thousand |
| Accounts receivables | -602.00 | -602.00 | 566.38 Thousand | -389.18 Thousand | 450.55 Thousand | -283.99 Thousand |
| Accounts payables | 1.33 Million | 1.33 Million | 766.63 Thousand | 1.97 Million | -618.01 Thousand | 819.41 Thousand |
| Inventory | - | - | 236.45 Million | 236.45 Million | -135.98 Thousand | -115.66 Thousand |
| Other working capital | -66.95 Thousand | -66.95 Thousand | 90.07 Thousand | -236.36 Million | -300 Thousand | -450 Thousand |
| Cash at beginning of period | 771.94 Thousand | 771.94 Thousand | 202.04 Thousand | 64.62 Thousand | 1.89 Million | 4.14 Million |
| Cash at end of period | 83.72 Thousand | 83.72 Thousand | 771.94 Thousand | 202.04 Thousand | 6.64 Million | 1.89 Million |
| Capital Expenditure | - | - | -3875.00 | -3875.00 | -101.17 Thousand | -1.82 Million |
| Effect of forex changes on cash | - | - | -25.31 Thousand | -100.89 Thousand | - | - |
| Net cash flow / Change in cash | -688.22 Thousand | -688.22 Thousand | 569.89 Thousand | 137.42 Thousand | 4.74 Million | -2.24 Million |
| Free Cash Flow | -1.38 Million | -1.38 Million | -2.46 Million | 108.23 Thousand | -12.61 Million | -7.92 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.88 Million | -54.12 Thousand | -355.73 Thousand | -2.89 Million | -874.72 Thousand | -296.04 Thousand |
| Depreciation & Amortization | 40.62 Thousand | 40.54 Thousand | 40.74 Thousand | 206.05 Thousand | 51.62 Thousand | 51.47 Thousand |
| Deferred income taxes | - | - | - | -5521.00 | -5326.83 | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.07 Million | 120.45 Thousand | 289.43 Thousand | 1.27 Million | 122.12 Thousand | -82.51 Thousand |
| Other non-cash items | 11.79 Thousand | -17.15 Thousand | 11.38 Thousand | 83.71 Thousand | 505.05 Thousand | 33.92 Thousand |
| Investing Cash Flow | - | - | - | 500 Thousand | 7402.30 | 1493.54 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | 482.41 Thousand | 7402.30 | 1493.54 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 17.58 Thousand | - | - |
| Financing Cash Flow | - | - | - | 200 Thousand | 200 Thousand | - |
| Debt repayment | - | - | - | -192.96 Thousand | -192.96 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 392.96 Thousand | 392.96 Thousand | - |
| Accounts receivables | 333.88 Thousand | -122.05 Thousand | -208.36 Thousand | -602.00 | -602.00 | - |
| Accounts payables | 1.52 Million | 249.55 Thousand | 539.84 Thousand | 1.33 Million | 103.66 Thousand | -95.98 Thousand |
| Inventory | -1.85 Million | -249.55 Thousand | 3508.00 | - | -103.66 Thousand | - |
| Other working capital | 2.07 Million | 242.51 Thousand | -45.54 Thousand | -66.95 Thousand | 122.72 Thousand | 13.47 Thousand |
| Cash at beginning of period | 159.27 Thousand | 69.54 Thousand | 83.72 Thousand | 771.94 Thousand | 79.64 Thousand | 372.79 Thousand |
| Cash at end of period | 400.1 Thousand | 159.27 Thousand | 69.54 Thousand | 83.72 Thousand | 83.72 Thousand | 79.64 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | -7402.30 | - |
| Net cash flow / Change in cash | 240.82 Thousand | 89.72 Thousand | -14.17 Thousand | -688.22 Thousand | 4073.00 | -293.14 Thousand |
| Free Cash Flow | 240.82 Thousand | 89.72 Thousand | -14.17 Thousand | -1.38 Million | -195.92 Thousand | -293.14 Thousand |
6363
MQY
AQUA
PETWW
MKL
011170